Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease
NCT00373815
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
10
Enrollment
OTHER
Sponsor class
Stopped
high incidence of TTP, poor recrual
Conditions
Graft Versus Host Disease
Interventions
DRUG:
Everolimus
Sponsor
University Hospital Tuebingen